Summary: By using novel methods to compare Wilms tumor genomic datasets and in vitro assays, we identified aberrant gene expression programs linked to enhanced DNA-binding affinity that result from the relapse-associated Q177R mutation in SIX1 and SIX2. This evidence concerns the gene SIX2 and Wilms tumor.